Report : South & Central America Platelet Rich Plasma Tube Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Usage (Skin Rejuvenation, Hair Restoration, Orthopedics, Surgical Oncology, Gynecology, and Others), Volume (Less Than 5 ML, 6 ML TO 10 ML, and More Than 10 ML), and End User (MedSpas, Dermatology Offices, Hospitals and Healthcare Practices, Tricologist Practices, and Others)
At 14.6% CAGR, the South & Central America Platelet Rich Plasma Tube Market is speculated to be worth US$ 109.91 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the South & Central America platelet rich plasma tube market was valued at US$ 48.42 million in 2022 and is expected to reach US$ 109.91 million by 2028, registering a CAGR of 14.6% from 2022 to 2028. Increasing cases of sports injuries and incorporation of platelet-rich plasma in regenerative medicine are the critical factors attributed to the South & Central America platelet rich plasma tube market expansion.
To treat sports injuries, medical professionals with high degrees of skills and the best techniques are required for an early return to play. A surge in participation in sports activities leads to associated sports injuries. According to the National Safety Council (NSC), in 2021, about 409,000 injuries were reported due to exercise equipment, the most in any sports and recreation category. PRP injections can help stimulate the healing of a sports-related injury of athletes who underwent a minimally invasive procedure. A PRP treatment is performed by collecting the patient's blood with a blood centrifugation process (which separates plasma from the blood cells) and then injected back into the injured area. The higher level of plasma harvested in the injection comprises growth factors that stimulate faster healing and recovery of the injury. PRP injections have become popular in treating tendon, muscle, and ligament injuries. According to the report published by the National Library of Medicine in 2021, an increase in injury rates in soccer was observed in recent years. This high incidence of sport-related injury is often attributed to great sports specialization and intense practice at an early age. Therefore, rising sports injuries increase the demand for PRP therapy among athletes, driving the growth of the South & Central America platelet-rich plasma (PRP) tube market.
On the contrary, high cost and adverse effects of platelet-rich plasma treatment hurdles the growth of South & Central America platelet rich plasma tube market.
Based on usage, the South & Central America platelet rich plasma tube market is segmented into skin rejuvenation, hair restoration, orthopedics, surgical oncology, gynecology, and others. The others segment held 24.8% share of South & Central America platelet rich plasma tube market in 2022, amassing US$ 11.99 million. It is projected to garner US$ 19.52 million by 2028 to expand at 8.5% CAGR during 2022–2028.
Based on volume, the South & Central America platelet rich plasma tube market is segmented into less than 5 ml, 6ml to 10 ml, and more than 10 ml. The more than 10 ml segment held 61.8% share of South & Central America platelet rich plasma tube market in 2022, amassing US$ 29.94 million. It is projected to garner US$ 49.37 million by 2028 to expand at 8.7% CAGR during 2022–2028.
Based on end user, the South & Central America platelet rich plasma tube market is segmented into medspa, dermatology office, hospitals & healthcare practice, tricologist, and others. The hospitals & healthcare practice segment held 35.0% share of South & Central America platelet rich plasma tube market in 2022, amassing US$ 16.93 million. It is projected to garner US$ 28.18 million by 2028 to expand at 8.9% CAGR during 2022–2028.
Based on country, the South & Central America platelet rich plasma tube market has been categorized into Brazil, Argentina, the Rest of South & Central America. Our regional analysis states that Brazil captured 43.7% share of South & Central America platelet rich plasma tube market in 2022. It was assessed at US$ 21.15 million in 2022 and is likely to hit US$ 49.06 million by 2028, exhibiting a CAGR of 15.1% during the forecast period.
Key players profiles in the South & Central America platelet rich plasma tube market report AdvaCare Pharma USA LLC; ADVIN HEALTH CARE; BIO-X; Lingen Precision Medical Products Co Ltd; and Manso Medical Co Ltd, among others.
Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: sam@businessmarketinsights.com